Aim and Scope
JCAM aims to:
- Bridge the Gap: Integrate laboratory discovery with bedside clinical expertise.
- Promote Innovation: Support the adoption of AI and emerging technologies in diagnostics and surgery.
- Ensure Integrity: Adhere to COPE and ICMJE ethical standards to maintain high-impact scholarly communication.
- Global Accessibility: Provide a transparent, open-access venue for researchers from both developed and developing healthcare systems.
Scope of the Journal
JCAM welcomes high-quality submissions across eight primary thematic areas:
- Internal Medicine: Diagnostic advancements, chronic disease research, and patient-centered outcomes.
- Oncology: Molecular oncology, immunotherapy, targeted therapies, and precision medicine.
- Pediatrics: Neonatal care, developmental medicine, and pediatric infectious diseases.
- Psychiatry: Neuropsychiatry, digital mental health, and psychopharmacology.
- Surgery: Minimally invasive/robotic techniques, trauma surgery, and postoperative outcomes.
- Molecular Medicine: Genomics, biomarker discovery, and regenerative medicine.
- Clinical Pharmacology: Pharmacokinetics, drug safety, and personalized pharmacotherapy.
- Artificial Intelligence in Clinical Care: Machine learning diagnostics, predictive analytics, and ethical AI validation.
Article Categories Accepted
To cater to diverse clinical evidence, JCAM accepts:
- Original Research Articles (Full-length empirical studies)
- Review Articles & Systematic Reviews (including Meta-analyses)
- Short Communications (Preliminary findings or brief reports)
- Case Reports & Case Series (Unique clinical observations)
- Editorials & Commentaries (Expert perspectives)
- Clinical Practice Guidelines (Evidence-based protocols)